MetLife, Inc. with ticker code (MET) now have 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price High/Low ranges between 90 and 60 calculating the average target price we see $81.14. Given that the stocks previous close was at $55.43 and the analysts are correct then there would likely be a percentage uptick in value of 46.4%. Also worth taking note is the 50 day moving average now sits at $66.97 and the 200 day moving average is $67.40. The total market capitalization for the company now stands at $44,580m. You can visit the company’s website by visiting: https://www.metlife.com
The potential market cap would be $65,258m based on the market consensus.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
The company has a dividend yield of 3.54% with the ex dividend date set at 6-2-2023 (DMY).
Other points of data to note are a P/E ratio of 19.82, revenue per share of 87.02 and a 0.33% return on assets.
